₹15.57
+₹0.07 (+0.45%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹16 Cr
P/E
-42.08
ROE
1.85%
ROCE
3.44%
About Norris Medicines Ltd
Norris Medicines manufactures generic pharmaceutical tablets, capsules, syrups, and suspension form products. The Company produces a range of antibiotic, anti-inflammatory, and analgesic products, as well as products for nutrition, anxiety, diabetes, and
Founded
1990
CEO
Vimal D Shah
Employees
45
HQ
Ankleshwar, Gujarat
About Norris Medicines Ltd
Norris Medicines manufactures generic pharmaceutical tablets, capsules, syrups, and suspension form products. The Company produces a range of antibiotic, anti-inflammatory, and analgesic products, as well as products for nutrition, anxiety, diabetes, and
Founded:1990
CEO:Vimal D Shah
Employees:45
HQ:Ankleshwar, Gujarat
Finished Products
1Other operating Revenues
₹5.44Cr2Sale of Products
₹5.22Cr3Job Work
₹0.41Cr4Damaged & ExpiryGood
₹0.38CrRaw Materials
1Raw Material consumed
₹6.53CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹20
52W Low
₹12
Volume72
Avg VolumeN/A
Beta0.37
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
-42.08x
Valuation
P/B Ratio
N/A
Valuation
EPS
₹-0.37
Valuation
Dividend Yield
0.00%
Valuation
ROE
1.85%
Profitability
ROCE
3.44%
Profitability
Revenue by Segment
Contribution & growth by business line
Manufacturing of pharmaceuticalRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
-1.42x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
-11.4%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.